Trially: Valuation, Funding & Investors
Trially is an AI-driven platform revolutionizing clinical trial recruitment by efficiently matching, engaging, and enrolling patients in trials. The platform utilizes HIPAA-compliant AI technology to analyze medical data, significantly reducing manual processes and enhancing enrollment rates. Trially's offerings include patient matching, AI-driven outreach, and feasibility analytics, designed to streamline recruitment for physicians, research sites, CROs, and pharmaceutical sponsors, ultimately accelerating access to life-saving treatments.
Leadership & Board
Latest Estimated Valuation
- Total Amount Raised
- $5M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $5M
- Latest Funding Round
- Seed Round
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Sep 16, 2025 | Seed Round | $4.70M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Gaingels | Seed Round |
| The Council | Seed Round |
| Blu Ventures | Seed Round |
| Flyover Capital | Seed Round |
| Alpaca | Seed Round |
| Atria | Seed Round |
| Looking Glass Capital | Seed Round |
| Redbud | Seed Round |
Similar Companies
A snapshot of private companies similar to Trially, helping you discover and navigate related company profiles.









